David Southwell: CEO of Volastra Therapeutics

Episode 88

0:00-31:26

David Southwell, CEO of Volastra Therapeutics, shares his insights about leadership in biopharma and how Volastra is working to discover and develop oncology therapeutics targeting chromosomal instability, a vulnerability of cancers.

Publisher

BioBoss

Link

wyantsimboli.com/bioboss/david-southwell-ceo-of-volastra-therapeutics

Published

February 28, 2026

Duration

31 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

John Simboli

B

BioBoss

@bioboss

#davidsouthwell #volastratherapeutics #lifesciences #investing

The Nile